Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors

被引:1
|
作者
Fan, Dongwei [1 ]
Li, Xuanhe [2 ]
Yu, Yousheng [1 ]
Wang, Xingliang [1 ]
Fang, Jun [1 ]
Huang, Cheng [1 ,3 ]
机构
[1] West Anhui Hlth Vocat Coll, Affiliated Hosp, Dept Gen Surg, Luan 237000, Anhui, Peoples R China
[2] Bengbu Med Coll, Affiliated Hosp 1, Dept Surg Oncol, Bengbu 233000, Anhui, Peoples R China
[3] West Anhui Hlth Vocat Coll, Affiliated Hosp, Dept Gen Surg, 73 Mozitan Rd, Luan 237000, Anhui, Peoples R China
关键词
gastroenteropancreatic neuroendocrine tumor; clinical and pathological characteristics; prognostic factors; SERUM CHROMOGRANIN-A; CONSENSUS GUIDELINES; DIAGNOSIS; MANAGEMENT; CLASSIFICATION; RATIONALE; NEOPLASMS; FEATURES; TRACT;
D O I
10.3892/mco.2023.2681
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are one of the most common types of NETs, accounting for 65-75% of all NETs. However, epidemiological characteristics of patients with GEP-NETs in China are still lacking. The present retrospective study aimed to investigate the local epidemiology of GEP-NETs and assess the prognostic factors in China. The data of 267 patients with GEP-NETs who were admitted to the First Affiliated Hospital of Bengbu Medical College (Bengbu, China) and the Affiliated Hospital of West Anhui Health Vocational College (Lu'an, China) were retrospectively reviewed. The clinical and pathological characteristics of the patients, as well as follow-up information, were collected, and the 5-year survival rate was calculated. Kaplan-Meier curves and log-rank analysis were used to analyze the prognostic factors. The stomach (100/267; 37.5%) was the most common site of GEP-NETs and the liver (25/39; 64.1%) was the most common metastatic site. A total of 166 (62.2%) and 219 (82.0%) patients had positive results for chromogranin A (CgA) and synaptophysin (Syn), respectively. The percentage of patients with tumor grade G1, G2 and G3 was 33.3, 21.0 and 45.7%, respectively. The 5-year overall survival rate was 79.7%, and the age, tumor site, distant metastasis and tumor grading upon diagnosis were all prognostic factors. In conclusion, the present case series investigated the epidemiology and prognostic factors of GEP-NETs in China. CgA and Syn could be used as diagnostic markers for NETs and the stomach was the most common primary tumor site. Lymph node metastasis, tumor site, distant metastasis and tumor grading were important prognostic factors.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Expression signature of gastroenteropancreatic neuroendocrine tumors in correlation to clinical outcome at ENETS centre of excellence Zurich
    Duschek, Silvia
    Curioni-Fontecedro, A.
    Hiltbrunner, S.
    Friemel, J.
    Weber, A.
    Siebenhuner, A.
    SWISS MEDICAL WEEKLY, 2019, 149 : 12S - 12S
  • [42] Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
    Huiying Shi
    Chen Jiang
    Qin Zhang
    Cuihua Qi
    Hailing Yao
    Rong Lin
    Diagnostic Pathology, 15
  • [43] Nutritional Complications and the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Laing, Erin
    Kiss, Nicole
    Michael, Michael
    Krishnasamy, Meinir
    NEUROENDOCRINOLOGY, 2020, 110 (05) : 430 - 441
  • [44] Survival of Patients With Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus
    Thapi, Sahityasri
    Baeg, Kiwoon
    Kim, Michelle K.
    Gallagher, Emily J.
    PANCREAS, 2021, 50 (09) : 1293 - 1297
  • [45] Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
    Shi, Huiying
    Jiang, Chen
    Zhang, Qin
    Qi, Cuihua
    Yao, Hailing
    Lin, Rong
    DIAGNOSTIC PATHOLOGY, 2020, 15 (01)
  • [46] Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a German referral center
    Pape, UF
    Böhmig, M
    Berndt, U
    Tiling, N
    Wiedenmann, B
    Plöckinger, U
    GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE: MOLECULAR AND CELL BIOLOGICAL ASPECTS, 2004, 1014 : 222 - 233
  • [47] Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors
    Kamp, K.
    Alwani, R. A.
    Korpershoek, E.
    Franssen, G. J. H.
    de Herder, W. W.
    Feelders, R. A.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (03) : 271 - 280
  • [48] Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors
    Keck, Kendall J.
    Maxwell, Jessica E.
    Menda, Yusuf
    Bellizzi, Andrew
    Dillon, Joseph
    O'Dorisio, Thomas M.
    Howe, James R.
    SURGERY, 2017, 161 (01) : 272 - 278
  • [49] Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
    Keck, Kendall
    Maxwell, Jessica
    Menda, Yusuf
    Bellizzi, Andrew
    Dillon, Joseph
    O'Dorisio, Thomas
    Howe, James
    PANCREAS, 2017, 46 (03) : 441 - 442
  • [50] Clinical and pathological characteristics and prognosis of 132 cases of rectal neuroendocrine tumors
    Yong-Jun Yu
    Yu-Wei Li
    Yang Shi
    Zhao Zhang
    Min-Ying Zheng
    Shi-Wu Zhang
    World Journal of Gastrointestinal Oncology, 2020, (08) : 893 - 902